CARISMA THERAPEUTICS INC

DOSSIER · 13F Holders · Q1 2026

CARM

CARISMA THERAPEUTICS INC

5 institutions still hold CARISMA THERAPEUTICS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 14216R101·5 13F holders·last filed Mar 31, 2026

Market cap

—

13F value held

$48K

visible holders

Holders

5

filers reporting

Concentration

99.96%

Merck & Co., Inc. #1

top holder share

AI Holders Summary · Q1 2026

5 institutions reported CARM in Q1 2026. Merck & Co., Inc. leads at 100.0% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter

01

Merck & Co., Inc.

CIK 0000310158

$48K1.5M0.01%Q1 2026 02

ORG Partners LLC

CIK 0001979372

$82000.00%Q4 2025 03

Golden State Equity Partners

CIK 0001845003

$62000.00%Q1 2026 04

Union Bancaire Privee, UBP SA

CIK 0001716607

$47850.00%Q2 2026 05

CONCOURSE FINANCIAL GROUP SECURITIES, INC.